HUTCHMED (HCM) Competitors $16.75 -0.08 (-0.48%) (As of 11/19/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends HCM vs. PCVX, CTLT, SRPT, RVMD, QGEN, ITCI, ROIV, ASND, LEGN, and ELANShould you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Vaxcyte (PCVX), Catalent (CTLT), Sarepta Therapeutics (SRPT), Revolution Medicines (RVMD), Qiagen (QGEN), Intra-Cellular Therapies (ITCI), Roivant Sciences (ROIV), Ascendis Pharma A/S (ASND), Legend Biotech (LEGN), and Elanco Animal Health (ELAN). These companies are all part of the "pharmaceutical products" industry. HUTCHMED vs. Vaxcyte Catalent Sarepta Therapeutics Revolution Medicines Qiagen Intra-Cellular Therapies Roivant Sciences Ascendis Pharma A/S Legend Biotech Elanco Animal Health HUTCHMED (NASDAQ:HCM) and Vaxcyte (NASDAQ:PCVX) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Which has higher valuation & earnings, HCM or PCVX? HUTCHMED has higher revenue and earnings than Vaxcyte. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHUTCHMED$838M3.48$100.78MN/AN/AVaxcyteN/AN/A-$402.27M-$4.60-18.93 Is HCM or PCVX more profitable? HUTCHMED's return on equity of 0.00% beat Vaxcyte's return on equity.Company Net Margins Return on Equity Return on Assets HUTCHMEDN/A N/A N/A Vaxcyte N/A -23.53%-22.20% Does the MarketBeat Community believe in HCM or PCVX? HUTCHMED received 271 more outperform votes than Vaxcyte when rated by MarketBeat users. However, 74.58% of users gave Vaxcyte an outperform vote while only 66.32% of users gave HUTCHMED an outperform vote. CompanyUnderperformOutperformHUTCHMEDOutperform Votes31566.32% Underperform Votes16033.68% VaxcyteOutperform Votes4474.58% Underperform Votes1525.42% Does the media prefer HCM or PCVX? In the previous week, Vaxcyte had 8 more articles in the media than HUTCHMED. MarketBeat recorded 10 mentions for Vaxcyte and 2 mentions for HUTCHMED. Vaxcyte's average media sentiment score of 0.77 beat HUTCHMED's score of -0.35 indicating that Vaxcyte is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HUTCHMED 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Vaxcyte 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend HCM or PCVX? HUTCHMED currently has a consensus target price of $20.55, suggesting a potential upside of 22.69%. Vaxcyte has a consensus target price of $147.50, suggesting a potential upside of 69.38%. Given Vaxcyte's stronger consensus rating and higher probable upside, analysts clearly believe Vaxcyte is more favorable than HUTCHMED.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HUTCHMED 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Vaxcyte 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in HCM or PCVX? 8.8% of HUTCHMED shares are held by institutional investors. Comparatively, 96.8% of Vaxcyte shares are held by institutional investors. 3.6% of HUTCHMED shares are held by company insiders. Comparatively, 3.1% of Vaxcyte shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more risk & volatility, HCM or PCVX? HUTCHMED has a beta of 0.85, suggesting that its share price is 15% less volatile than the S&P 500. Comparatively, Vaxcyte has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. SummaryVaxcyte beats HUTCHMED on 8 of the 14 factors compared between the two stocks. Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Get HUTCHMED News Delivered to You Automatically Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCM vs. The Competition Export to ExcelMetricHUTCHMEDPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.92B$6.39B$5.00B$8.83BDividend YieldN/A8.11%5.18%4.07%P/E RatioN/A10.08132.0617.53Price / Sales3.48382.831,242.7299.30Price / Cash26.7622.1633.2632.45Price / Book3.925.414.654.65Net Income$100.78M$153.11M$118.24M$225.37M7 Day Performance-1.70%-4.23%-2.46%-2.13%1 Month Performance-19.86%-8.68%-4.03%-0.20%1 Year Performance-9.65%27.80%29.46%24.41% HUTCHMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCMHUTCHMED1.2225 of 5 stars$16.75-0.5%$20.55+22.7%-10.0%$2.92B$838M0.001,988Analyst DowngradeNews CoveragePositive NewsPCVXVaxcyte3.3225 of 5 stars$87.08+0.7%N/A+69.2%$10.85BN/A-18.93160CTLTCatalent3.0688 of 5 stars$58.85+0.1%N/A+47.6%$10.68B$4.38B-26.0416,900SRPTSarepta Therapeutics4.9433 of 5 stars$106.62+1.9%N/A+28.2%$10.18B$1.24B85.301,314Analyst DowngradeRVMDRevolution Medicines2.8289 of 5 stars$56.47+4.1%N/A+164.7%$9.50B$11.58M-15.73443QGENQiagen4.4478 of 5 stars$40.81-0.4%N/A+0.6%$9.31B$1.97B104.645,967ITCIIntra-Cellular Therapies4.4993 of 5 stars$83.35+1.1%N/A+45.7%$8.84B$464.37M-95.80560Positive NewsROIVRoivant Sciences3.2961 of 5 stars$11.31+1.3%N/A+26.1%$8.36B$124.79M2.00860ASNDAscendis Pharma A/S3.0505 of 5 stars$124.44+2.0%N/A+31.0%$7.55B$288.08M-15.40640Analyst UpgradeShort Interest ↑News CoverageLEGNLegend Biotech1.8831 of 5 stars$38.40+2.6%N/A-40.5%$7.00B$520.18M-40.421,800Analyst RevisionELANElanco Animal Health4.0694 of 5 stars$13.31-1.0%N/A+12.6%$6.58B$4.42B33.289,300 Related Companies and Tools Related Companies PCVX Alternatives CTLT Alternatives SRPT Alternatives RVMD Alternatives QGEN Alternatives ITCI Alternatives ROIV Alternatives ASND Alternatives LEGN Alternatives ELAN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HCM) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredAmerica’s Pro-Crypto AgendaCash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HUTCHMED (China) Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share HUTCHMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HCM Stock Alerts